<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Secondary or therapy related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> may develop following treatment with <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> and radiotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>The condition may also follow high dose therapy for malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We describe two patients who developed secondary <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The first is a 76-year old female with a low grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> who developed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> with <z:mp ids='MP_0004026'>monosomy</z:mp> 7 </plain></SENT>
<SENT sid="4" pm="."><plain>Secondary <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> was diagnosed 24 months after treatment with <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> (total dose of 900 mg) and 12 months after treatment with trophosphamide (total dose of 24 g) </plain></SENT>
<SENT sid="5" pm="."><plain>The second patient was a 48-year old male who underwent autologous bone marrow transplantation for a relapsed low grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Following autografting he had persistent <z:hpo ids='HP_0001903'>anemia</z:hpo> and trombocytopenia </plain></SENT>
<SENT sid="7" pm="."><plain>Secondary <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with complex karyotype was diagnosed 54 months after high dose therapy </plain></SENT>
<SENT sid="8" pm="."><plain>He died nine months later of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
</text></document>